Codexis (CDXS) Cash from Investing Activities (2010 - 2026)

Codexis (CDXS) recorded quarterly Cash from Investing Activities of -$1.1 million in Q1 2026, down 119.45% quarter-over-quarter from $5.7 million in Q4 2025, and down 109.44% on a YoY basis from $11.8 million in Q1 2025.

Codexis (CDXS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Codexis' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 109.44% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $10.6 million (up 163.8% YoY), while the FY2025 annual figure was $23.5 million, up 141.25% from the prior year.
  • Cash from Investing Activities was -$1.1 million for Q1 2026 at Codexis, down from $5.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $11.8 million in Q1 2025 to a low of -$28.6 million in Q1 2024.
  • Historically, Cash from Investing Activities has averaged -$3.1 million across 5 years, with a median of -$1.1 million in 2026.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities surged 3245.45% in 2023, then slumped 1624.19% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $33000.0 in 2022, then soared by 3245.45% to $1.1 million in 2023, then slumped by 359.33% to -$2.9 million in 2024, then soared by 299.55% to $5.7 million in 2025, then plunged by 119.45% to -$1.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$1.1 million (Q1 2026), $5.7 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.89 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -431.90 Mn
9 Abivax 95.45 Bn 95.45 Bn - 579,519.10
10 Codexis 226.01 Mn 160.87 Mn 13.18 Mn -1.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.11 Mn
Mar 31, 2026 -1.11 Mn
Dec 31, 2025 5.71 Mn
Dec 31, 2025 5.71 Mn
Sep 30, 2025 6.39 Mn
Sep 30, 2025 6.39 Mn
Jun 30, 2025 -367,000.00
Jun 30, 2025 -367,000.00
Mar 31, 2025 11.77 Mn
Mar 31, 2025 11.77 Mn
Dec 31, 2024 -2.86 Mn
Dec 31, 2024 -2.86 Mn
Sep 30, 2024 1.53 Mn
Sep 30, 2024 1.53 Mn
Jun 30, 2024 -27.09 Mn
Jun 30, 2024 -27.09 Mn
Mar 31, 2024 -28.56 Mn
Mar 31, 2024 -28.56 Mn
Dec 31, 2023 1.10 Mn
Dec 31, 2023 1.10 Mn